EVAX

EVAXION BIOTECH A/S

EVAX·29970R204·US·ADR·Healthcare - Biotechnology

EVAX (EVAXION BIOTECH A/S) is held by 8 institutional investors as of Q2 2026. Largest holders: Rathbones Group PLC ($141,741), CITADEL ADVISORS LLC ($113,410), RENAISSANCE TECHNOLOGIES LLC ($104,780). Net institutional sentiment: Mixed.

8
Holders
(1 Elite)
$575,695
Total Value
67% (6)
Consensus
4 buying - 2 selling
13F: Insider & Congress: Updated regularly
EVAX

Smart Money Verdict

View all
Loading verdict
Held by 8 funds
1 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for EVAX.

Top Holders

Checking access…
Action
Unchanged
45,723$141,7410.0%-3.85%
0
Increased
36,584(+105.8%)$113,4100.0%-3.53%
24
Decreased
33,800(-13.8%)$104,7800.0%-3.85%
0
Increased
21,849(+0.9%)$67,7230.0%-31.02%
21
New
20,581$63,8010.0%-3.23%
32
Decreased
12,899(-41.5%)$39,9870.0%-3.85%
0
Unchanged
8,000$24,8000.0%-37.24%
0
New
6,275$19,4530.0%-3.23%
29
EVAXEVAXEVAXION BIOTECH A/S

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used